This Bromine Chemicals Stock Rises 50% in 1 Year: The Battery Bet Behind the Move
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Neogen Chemicals: CMP Rs 2,371.70 on 17 Sep 2026, up 50% in 1 year. 52W range Rs 966.70 to Rs 2,483.90. Market cap Rs 6,303 Cr. Q1 FY27 PAT Rs 17.11 Cr.
Quick Answer
Neogen Chemicals Ltd is the bromine chemicals stock that gained 50.00% between 17 September 2025 and 17 September 2026, moving from Rs 1,581.10 to Rs 2,371.70. A lithium-ion battery materials build-out that finally started producing revenue, two quarters of margin expansion and a Rs 600 crore placement completed on 16 September 2026 drove the move. Debt to equity near 1.71 and a trailing price-to-earnings ratio close to 177 are the two numbers that argue against chasing this bromine chemicals stock here.
This bromine chemicals stock has risen approximately 50% in one year, and almost none of that gain came from bromine. Verified prices show the share at Rs 1,581.10 on 17 September 2025 and Rs 2,371.70 on 17 September 2026, a move of 50.00%. The path was odd for a bromine chemicals stock: it first fell to Rs 966.70 in December 2025 before more than doubling off that low.
The company behind this bromine chemicals stock is Neogen Chemicals Ltd (NSE: NEOGEN), a Mumbai-headquartered maker of bromine and lithium based specialty chemicals that has spent three years building a lithium-ion battery materials business. The Neogen Chemicals share price closed at Rs 2,302.40 on 16 September 2026 and traded near Rs 2,371.70 on 17 September, about 4.5% below its 52-week high of Rs 2,483.90 from 18 August 2026.
Click Here – Get Free Investment Predictions
Bromine Chemicals Stock Returns: 50% in One Year, But Look at the Path
The one-year gain is 50.00%, computed from closing prices on 17 September 2025 and 17 September 2026. No stock split or bonus issue fell in the window, so this is genuine price appreciation. Share count did rise through the placement completed on 16 September 2026.
Here is how this bromine chemicals stock has performed, all measured against the Neogen Chemicals share price of Rs 2,371.70 on 17 September 2026:
| Period | Starting Close (Rs) | Return |
|---|---|---|
| 1 Month (17 Aug 2026) | 2,270.10 | Up 4% |
| 6 Months (17 Mar 2026) | 1,359.30 | Up 74% |
| 1 Year (17 Sep 2025) | 1,581.10 | Up 50% |
| 3 Years (15 Sep 2023) | 1,739.50 | Up 36% |
| 5 Years (17 Sep 2021) | 1,130.25 | Up 110% |
The three-year number is the honest check on this bromine chemicals stock. A 36% gain over three years works out to roughly 11% a year, and the five-year figure of 110% still trails what the last six months alone delivered. This bromine chemicals stock spent two and a half years going nowhere and then re-rated once the battery materials plan started producing revenue.
The 52-week range says it more bluntly. This bromine chemicals stock printed a low of Rs 966.70 on 10 December 2025 and a high of Rs 2,483.90 on 18 August 2026, a spread of about 157% inside twelve months. That is the volatility to price in before treating it as a steady compounder.
Why Did This Bromine Chemicals Stock Rise 50% in One Year?
This bromine chemicals stock rose because four specific, dated events changed the earnings trajectory: the Q4 FY26 results in May 2026, the start of electrolyte trial production on 25 May 2026, a sharp Q1 FY27 profit beat in late July 2026, and a Rs 600 crore fundraise that closed on 16 September 2026.
1. Q4 FY26 Results Reversed a Bad Year
Neogen Chemicals reported March 2026 quarter revenue of Rs 247.54 crore, up about 22% year on year, with EBITDA of Rs 44.89 crore and an operating margin of 18.22%. Net profit came in at Rs 11.39 crore against Rs 3.69 crore in the December 2025 quarter. The inorganic chemicals segment, which houses the lithium salts business, grew about 145% in that quarter.
FY26 profit had fallen to Rs 28.75 crore from Rs 34.83 crore even though revenue rose to Rs 868.10 crore from Rs 781.57 crore. Q4 was the first quarter in a year with margin expansion rather than compression, and this bromine chemicals stock climbed from around Rs 1,180 in late March 2026 to above Rs 1,630 by late April.
2. Electrolyte Trial Production Started on 25 May 2026
On 25 May 2026 the company confirmed that trial production of lithium-ion battery electrolyte had begun at its Dahej facility, with full-scale commissioning targeted for September 2026 and commercial revenue from the second half of FY27. That timeline is now the single most important date for this bromine chemicals stock.
Japanese licensed technology is why the project cost was revised upward. Total planned battery materials investment is now approximately Rs 1,795 crore: Dahej Phase 1 at Rs 428 crore targeted for February 2027 and Pakhajan Phase 2 at Rs 1,367 crore targeted for March 2027.
3. The Morita Joint Venture for Electrolyte Salt
Neogen Ionics, the battery materials subsidiary, signed a joint venture with Japan’s Morita Investment Limited to make solid LiPF6 salt in India. Neogen Ionics holds 80% and Morita 20%, with the Japanese partner committing about USD 20 million. The pact was signed on 31 August 2025 and concluded in November 2025.
LiPF6 is the salt that makes a lithium-ion electrolyte work, and almost all of India’s requirement is imported. The venture is positioned as the country’s first non-FEOC-compliant electrolyte salt plant, which hands this bromine chemicals stock a sourcing advantage with customers who have to police supply-chain origin.
4. Q1 FY27 Results and the Rs 600 Crore QIP
The June 2026 quarter was the cleanest print this bromine chemicals stock has delivered in years. Revenue of Rs 254.15 crore was up about 35% year on year, EBITDA rose to Rs 52.09 crore, the operating margin expanded to 20.89% from 17.53%, and net profit reached Rs 17.11 crore against Rs 10.26 crore. Neogen Ionics revenue rose to roughly Rs 19 crore from Rs 5 crore a year earlier, and the inorganic segment grew about 158% to Rs 57 crore.
Alongside those numbers, the board approved a Rs 600 crore qualified institutional placement on 24 July 2026, aimed at the debt that has held this bromine chemicals stock back. The issue launched on 11 September 2026 and closed on 16 September 2026 at Rs 2,255 per share, covering 26,60,753 shares. Management says applying the proceeds to borrowings could cut annual finance costs by Rs 40 crore to Rs 50 crore.
Check the Univest Screener for Live Fundamentals of High-Return Stocks
Financials Behind the Bromine Chemicals Stock
Revenue has compounded while profit has gone backwards, the central tension in this bromine chemicals stock. Sales climbed from Rs 488.32 crore in FY22 to Rs 868.10 crore in FY26, but net profit fell from Rs 44.63 crore to Rs 28.75 crore. Net margin halved from 9.16% to 3.34%.
The quarterly sequence shows where this bromine chemicals stock turned:
| Quarter | Revenue (Rs Cr) | EBITDA (Rs Cr) | Operating Margin | Net Profit (Rs Cr) |
|---|---|---|---|---|
| Jun 2025 | 187.91 | 32.69 | 17.53% | 10.26 |
| Sep 2025 | 210.55 | 31.85 | 15.31% | 3.37 |
| Dec 2025 | 222.11 | 33.99 | 15.50% | 3.69 |
| Mar 2026 | 247.54 | 44.89 | 18.22% | 11.39 |
| Jun 2026 | 254.15 | 52.09 | 20.89% | 17.11 |
Two quarters of margin recovery is what re-rated this bromine chemicals stock. Diluted EPS moved from Rs 1.28 in September 2025 to Rs 6.29 in June 2026. Trailing EPS of Rs 12.99 against Rs 2,371.70 puts the price-to-earnings ratio near 177 versus an industry multiple around 36.
Management guides FY27 base-business revenue of Rs 950 crore to Rs 1,050 crore, plus about Rs 300 crore from battery chemicals, roughly Rs 200 crore from salts and Rs 100 crore from electrolytes.
Debt Levels Are the Weak Spot in This Bromine Chemicals Stock
Borrowings at this bromine chemicals stock more than doubled in a year, from Rs 597 crore in FY25 to Rs 1,395 crore in FY26, with consolidated net debt of approximately Rs 1,295 crore at the end of FY26. Debt to equity moved from 0.65 to 1.24 and sits around 1.71 on the latest reported basis.
The cost shows up directly in the profit line. FY26 operating profit before interest was Rs 116.19 crore, but profit before tax was only Rs 41.08 crore, implying finance and related charges of roughly Rs 75 crore against about Rs 49 crore in FY25. That single line explains why this bromine chemicals stock earned less on higher sales.
Cash flow is the other pressure point. Operating cash flow was negative Rs 231.48 crore in FY26 while capital expenditure ran at Rs 555.72 crore. The placement covers part of that gap, but with Rs 1,795 crore of projects to fund through March 2027 the balance sheet stays stretched.
Who Owns This Bromine Chemicals Stock? Institutions Have Been Trimming
Domestic institutions reduced exposure to this bromine chemicals stock through the rally. DII holding fell from 25.23% in September 2025 to 19.60% in June 2026, and FII holding slipped from 5.15% to 4.11% over the same four quarters.
| Shareholder | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Promoters | 51.23% | 51.23% | 51.23% | 53.01% |
| FIIs | 5.15% | 4.57% | 4.46% | 4.11% |
| DIIs | 25.23% | 21.99% | 22.64% | 19.60% |
| Public and others | 18.39% | 22.21% | 21.67% | 23.28% |
Promoter holding rose from 51.23% to 53.01% after the family reorganised its stake into trusts and a promoter entity added shares. No promoter pledge is disclosed in the filings reviewed.
Risks in This Bromine Chemicals Stock Investors Should Weigh
A price-to-earnings ratio near 177 against an industry multiple of about 36 leaves this bromine chemicals stock no room for disappointment, and return on equity is only 3.52%. If the electrolyte ramp slips by two quarters, the multiple has nothing to stand on.
Execution risk is concrete. A major fire hit the Dahej SEZ plant in March 2025, disrupting operations and leaving insurance claims receivable of approximately Rs 203 crore against recoveries of about Rs 140 crore. A replacement facility was due by June 2026, and any repeat at a site carrying this much capex would hurt this bromine chemicals stock badly.
Liquidity and volatility are real constraints in a bromine chemicals stock of this size. Market capitalisation is approximately Rs 6,303 crore, many sessions trade under 100,000 shares, and the stock fell about 9% on 10 November 2025 when September quarter profit dropped 69% to Rs 3 crore.
Technology and partner concentration also matter. The battery business runs on licensed Japanese technology and a joint venture partner for its salt chemistry, and revenue there was still only about Rs 36 crore in all of FY26. Add dilution from 26.60 lakh new shares and the per-share picture for this bromine chemicals stock gets harder.
Download the Univest iOS App or Univest Android App to track the Neogen Chemicals share price live
Neogen Chemicals Share: Analyst View
Analyst coverage of this bromine chemicals stock has not kept pace with the price. The most recent broker reports date from May 2026, when the shares traded near Rs 1,750.
Neogen Chemicals Share Price Target
A domestic brokerage set a Neogen Chemicals share price target of Rs 2,001 on 19 May 2026 and another put Rs 1,960 on 20 May 2026, with a blended consensus around Rs 1,873. All of those sit below the current price of Rs 2,371.70, so no verified brokerage target implies upside today.
The 52-week high of Rs 2,483.90 is the nearest resistance for this bromine chemicals stock. Any fresh Neogen Chemicals share price target depends on whether the electrolyte plant hits its H2 FY27 schedule.
Other Stocks to Track From the Same Return Screen
Beyond this bromine chemicals stock, a screen of NSE small-cap stocks ranked by 1-year return also includes related names such as Gujarat Ambuja Exports with a 1-year return of 45.04%, Rain Industries at 44.73% and Balaji Amines at 41.75%.
Among the names covered from that screen, MTAR Technologies returned 396.53% over one year. Readers can compare this bromine chemicals stock with the Nifty 50 benchmark and track each of these names on Univest before making any decision.
Conclusion
The 50% one-year gain in this bromine chemicals stock is verified and event-driven. Margins expanded for two straight quarters, the battery materials business finally has revenue, and a Rs 600 crore placement took some pressure off a stretched balance sheet.
The counterweight is equally real. Debt to equity near 1.71, negative operating cash flow, a trailing multiple close to 177 and institutions selling into strength all argue for caution on this bromine chemicals stock. The Neogen Chemicals share price is effectively an option on flawless execution at Dahej and Pakhajan through March 2027, so size any exposure accordingly and consult a SEBI-registered adviser.
Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Please verify all data independently before making any investment decision. Past returns do not guarantee future returns. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Which bromine chemicals stock rose 50% in one year?
Ans. Neogen Chemicals Ltd (NSE: NEOGEN) is the bromine chemicals stock that rose 50.00% between 17 September 2025 and 17 September 2026, from Rs 1,581.10 to Rs 2,371.70. It was among the stronger performers on a screen of NSE small-cap stocks ranked by one-year return, dated 17 September 2026.
Why did the Neogen Chemicals share price rise so sharply in 2026?
Ans. Four dated triggers re-rated this bromine chemicals stock: Q4 FY26 results in May 2026, the start of electrolyte trial production at Dahej on 25 May 2026, a Q1 FY27 net profit of Rs 17.11 crore in late July 2026, and a Rs 600 crore fundraise completed on 16 September 2026.
What is the Neogen Chemicals share price target for 2026?
Ans. No verified brokerage target above the current price exists. The most recent published research dates from May 2026, at Rs 2,001 from one domestic brokerage and Rs 1,960 from another, against a consensus near Rs 1,873. This bromine chemicals stock trades above every one of those published estimates.
How much debt does Neogen Chemicals carry?
Ans. Total borrowings at this bromine chemicals stock rose to Rs 1,395 crore in FY26 from Rs 597 crore in FY25, with consolidated net debt of approximately Rs 1,295 crore. Debt to equity moved from 0.65 to 1.24 over that year and stands near 1.71 on the latest reported basis.
What was the Neogen Chemicals QIP price and size?
Ans. The company raised Rs 600 crore by issuing 26,60,753 shares at Rs 2,255 each, with the placement closing on 16 September 2026. The board approved it on 24 July 2026, and management expects the proceeds to cut annual finance costs by Rs 40 crore to Rs 50 crore.
What are Neogen Chemicals Q1 FY27 results?
Ans. June 2026 quarter revenue at this bromine chemicals stock was Rs 254.15 crore, up about 35% year on year, with EBITDA of Rs 52.09 crore and net profit of Rs 17.11 crore against Rs 10.26 crore. The operating margin expanded to 20.89% from 17.53%, and the battery materials subsidiary contributed roughly Rs 19 crore versus Rs 5 crore a year earlier.
Is this bromine chemicals stock expensive at current levels?
Ans. On trailing numbers it is demanding, with a price-to-earnings ratio of approximately 177 against an industry multiple near 36, a price-to-book of 6.45 and return on equity of only 3.52%. The valuation assumes the Rs 1,795 crore battery materials build-out delivers on schedule through March 2027.
What is the 52-week high and low of the Neogen Chemicals share price?
Ans. The 52-week high is Rs 2,483.90, touched on 18 August 2026, and the 52-week low is Rs 966.70 from 10 December 2025. That spread measures how volatile this bromine chemicals stock has been over twelve months.
